PATENT CLAIM ANALYSIS

Application Number: 16195026
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "274000"]

Abstract:
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

Claim (Index 80):
The method of  claim 68 , wherein the disease is breast cancer.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14620903', '15355995', '15285792', '15970954', '14620950']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8651176352054611
- 35 USC 102 Novelty (BERT): 0.5863037680232044
- Combined Prediction Score: 0.8372362484872354
- Mean Citation Score: 579.3148279999998
- Max Citation Score: 609.79474
- Similarity Product: 386.6668223158288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test